Enhancing cardiac hemodynamic and pulsatility in heart failure via deep reinforcement learning: An in-silico and in-vitro validation study of percutaneous ventricular assist devices
- PMID: 40712369
- DOI: 10.1016/j.cmpb.2025.108975
Enhancing cardiac hemodynamic and pulsatility in heart failure via deep reinforcement learning: An in-silico and in-vitro validation study of percutaneous ventricular assist devices
Abstract
Background and objective: Percutaneous ventricular assist devices (pVADs) are critical for bridging heart failure (HF) patients to recovery or transplantation, yet existing control strategies-constant speed control and preprogrammed pulsatile control-lack adaptability to dynamic physiological variations, leading to reduced pulsatility and hemodynamic mismatch. This study proposes a deep reinforcement learning (DRL)-based adaptive control framework to optimize pVAD performance. The goal is to restore physiological pulsatile hemodynamics while autonomously adjusting to different HF conditions, heart rate fluctuations, and intra-cycle ejection phase variability.
Methods: Following a dual-validation pathway designed to bridge simulation with physical testing, a cardiovascular-pVAD in-silico model was developed and its fidelity confirmed against an in-vitro pulsatile mock circulatory loop. This validated platform was then used to design and test the DRL controller. A modified Deep Deterministic Policy Gradient (DDPG) algorithm with embedded LSTM layers was designed to capture temporal characteristics in aortic pressure (AOP) and aortic flow(AF) waveforms. The reward function integrated hemodynamic recoverability, pulsatile waveform similarity, and control stability and safety penalty.
Results: Comparative simulations and experiments demonstrated the DRL controller's superiority over conventional strategies. Under the moderate HF condition, DRL controller achieved near-physiological AOP (DTW-AOP: 1.17 vs. 16.42 for constant speed control; 2.72 for preprogrammed pulsatile control) and AF (DTW-AF: 21.23 vs. 71.74/48.96), with pulsatility indices (PI: 1.69 vs. 1.05/1.54) and pulse pressures (PP: 34.42 mmHg vs. 3.20/24.90 mmHg) closely matching healthy reference. The framework exhibited robust adaptability to heart rate shifts (75→120 bpm) and ejection phase delays (0.1 s), maintaining stability despite sensor noise and physiological perturbations.
Conclusions: This DRL controller enables real-time synchronization with native cardiac cycles and generalization across pathologies, paving the way for precision pVAD support and future clinical translation.
Keywords: Adaptive control; Deep reinforcement learning; Heart failure; Hemodynamics; Pulsatility; Ventricular assist devices.
Copyright © 2025. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Development of an Anatomy-Mimicking, Wave Transport-Preserving Mock Circulation Loop for Evaluating Pulsatile Hemodynamics as Supported by Cardiovascular Assist Devices.Cardiovasc Eng Technol. 2025 Aug;16(4):435-454. doi: 10.1007/s13239-025-00785-y. Epub 2025 Apr 22. Cardiovasc Eng Technol. 2025. PMID: 40261578 Free PMC article.
-
Novel Index for Non-Invasive Myocardial Recovery Assessment in LVAD-Supported Heart Failure Patients.IEEE Trans Biomed Eng. 2025 Jul;72(7):2178-2188. doi: 10.1109/TBME.2025.3537037. IEEE Trans Biomed Eng. 2025. PMID: 40031245
-
Numerical simulation analysis of multi-scale computational fluid dynamics on hemodynamic parameters modulated by pulsatile working modes for the centrifugal and axial left ventricular assist devices.Comput Biol Med. 2024 Feb;169:107788. doi: 10.1016/j.compbiomed.2023.107788. Epub 2023 Dec 1. Comput Biol Med. 2024. PMID: 38091724
-
Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model.Health Technol Assess. 2013 Nov;17(53):1-499, v-vi. doi: 10.3310/hta17530. Health Technol Assess. 2013. PMID: 24280231 Free PMC article.
-
Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.Health Technol Assess. 2024 Aug;28(38):1-237. doi: 10.3310/MLFA4009. Health Technol Assess. 2024. PMID: 39189844 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous